Rafferty Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Rafferty Asset Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-168,210	Closed	-$1.56M	–	1261
2022 Q1	$1.56M	Buy	168,210 +51,358	+44%	+$547K	0.01%	682
2021 Q4	$1.66M	Buy	116,852 +61,779	+112%	+$1.07M	0.01%	721
2021 Q3	$1.28M	Sell	55,073 -40,020	-42%	-$946K	0.01%	751
2021 Q2	$2.37M	Buy	95,093 +205	+0.2%	+$5.51K	0.01%	637
2021 Q1	$2.66M	Buy	94,888 +86,425	+1,021%	+$3.12M	0.02%	552
2020 Q4	$295K	Buy	+8,463	New	+$368K	﹤0.01%	814

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

EPL

EDBI Pte Ltd Singapore $94.4M AUM 32.71% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Rafferty Asset Management's FMTX Position: Q2 2022 in Review

Rafferty Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q2 2022, closing a stake of 168,210 shares — an estimated $1.56M sold.

Rafferty Asset Management first reported a position in FMTX in Q4 2020 and held it in 6 quarters. The position peaked at $2.66M in Q1 2021. 105 funds tracked by Wall St. Rank hold FMTX as of Q2 2022.

Rafferty Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Rafferty Asset Management sold 168,210 Forma Therapeutics Holdings, Inc. Common Stock shares in Q2 2022, an estimated $1.56M.
Rafferty Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Rafferty Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $2.66M in Q1 2021.
105 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q2 2022.

Based on Rafferty Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.